While precision medicine is expanding and transforming treatment opportunities for patients, it comes with a number of intellectual property challenges that must be overcome to ensure that the inherent technologies can continue to evolve. This panel will analyze the host of IP hurdles faced by claimants of personalized medicine patents and strategies for overcoming them. Topics of discussion include:

• Understanding the unique challenges of asserting IP of personalized medicine
• Best practices for tackling IP hurdles of precision medicine, including subject matter eligibility, proving infringement and software licensing

Speakers:
Paul Calvo, Director, Sterne, Kessler, Goldstein & Fox P.L.L.C.
Peter Corless, Partner, Fox Rothschild LLP

Please note there is a cost to attend.